4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Managing Cancer Care during the COVID-19 Pandemic and Beyond

      review-article
      1 , 2 , *
      Trends in Cancer
      Elsevier Inc.
      Cancer, COVID-19, pandemic, research, chemotherapy, immunotherapy

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          COVID-19 pandemic has posed insurmountable challenges to health care systems globally. Cancer therapy is complex, and outcomes are centered on timing. Many oncology societies and health ministries have issued guidelines for cancer care to enable oncologists and patients navigate the crisis. Lessons learned should inform care models for future pandemics.

          Related collections

          Author and article information

          Contributors
          Journal
          Trends Cancer
          Trends Cancer
          Trends in Cancer
          Elsevier Inc.
          2405-8033
          2405-8025
          27 April 2020
          27 April 2020
          Affiliations
          [1 ]Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
          [2 ]Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
          Author notes
          [* ]Corresponding Author: Vivek Subbiah, MD, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 1515 Holcombe Blvd – Unit 455, Houston, TX 77030. Tel.: +1 713 563 1930; fax: +1 713 792 0334. VSubbiah@ 123456mdanderson.org
          Article
          S2405-8033(20)30135-7
          10.1016/j.trecan.2020.04.005
          7184021
          224db666-ebf9-493c-a5f4-da952412a9ab
          © 2020 Elsevier Inc. All rights reserved.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          Categories
          Article

          cancer,covid-19,pandemic,research,chemotherapy,immunotherapy
          cancer, covid-19, pandemic, research, chemotherapy, immunotherapy

          Comments

          Comment on this article